1,3,5-trioxazatriquinane

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2009-2014
012320092014

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
We designed and synthesized novel triplet molecules with 1,3,5-trioxazatriquinane skeletons. One class comprises double-capped… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 4
Is this relevant?
2014
2014
We designed and synthesized the 1,3,5-trioxazatriquinane derivatives with m-hydroxyphenyl groups. These compounds include the… (More)
Is this relevant?
2014
2014
We designed and synthesized of 1,3,5-trioxazatriquinanes with o- or p-hydroxyphenyl rings as analogs of the κ opioid receptor… (More)
Is this relevant?
2012
2012
Novel double-capped triplet drugs, which have one pharmacophore unit and two epoxymethano or dimethylepoxymethano structures… (More)
Is this relevant?
2011
2011
We synthesized symmetrical and nonsymmetrical triplet drugs with 1,3,5-trioxazatriquinane skeletons. The isolation of key… (More)
Is this relevant?
2011
2011
An improved synthetic method for triplet drugs with the 1,3,5-trioxazatriquinane skeleton was developed that used p… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 5
  • figure 3
Is this relevant?
Review
2011
Review
2011
We will describe eight interesting reactions using naltrexone derivatives. Almost all these reactions are characteristic of… (More)
Is this relevant?
2009
2009
An alpha-hydroxyaldehyde derived from naltrexone was converted to an oxazoline dimer with ammonium chloride and sodium acetate in… (More)
Is this relevant?
2009
2009
An attempt to prepare a trimer having the 1,3,5-trioxazatriquinane skeleton led to discovery of a novel rearrangement reaction… (More)
Is this relevant?